Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes: ResearchMoz Albany,NY, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a...